Sinotau Pharmaceutical Group

This is an early, first-in-human study to check the safety and basic behavior of a new imaging agent called Flotufolastat F-18. The agent is designed to help detect prostate cancer. The study involves 6 healthy Chinese volunteers who will receive a single injection, followed by s…

This study is testing a new imaging injection called XTR004 to see if it can better detect significant blockages in the heart's arteries. It will involve about 395 adults with suspected or known stable coronary artery disease. The main goal is to compare the accuracy of pictures …

This study is testing a new type of PET scan to see if it can accurately identify which areas of damaged heart muscle are still alive and could recover after a procedure to restore blood flow. About 40-60 adults with heart failure caused by blocked arteries will receive the exper…